-
A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study -
Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study -
Clinical utility and cost savings in predicting inadequate response to anti-TNF therapies in rheumatoid arthritis -
Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients -
Network-based prediction of drug combinations -
Use Of The PrismRA Test To Stratify Patients For Response To Anti-TNF Therapy In RA -
PrismRA: a personalized medicine test that accurately predicts rheumatoid arthritis patients who will not respond adequately to tumor necrosis factor inhibitors -
Integrating personalized gene expression profiles into predictive disease-associated gene pools -
Tissue Specificity of Human Disease Module - Network-based in silico drug efficacy screening
-
A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome -
A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in Asthma - Uncovering disease-disease relationships through the incomplete interactome
-
A Proteome-Scale Map of the Human Interactome Network -
Developing New Drug Treatments in the Era of Network Medicine